These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 20681813)
1. Platelet-derived growth factor-BB release profile in gingival crevicular fluid after use of marginal periosteal pedicle graft as an autogenous guided tissue membrane to treat localized intrabony defects. Gamal AY; El-Shal OS; El-Aasara MM; Fakhry EM J Periodontol; 2011 Feb; 82(2):272-80. PubMed ID: 20681813 [TBL] [Abstract][Full Text] [Related]
2. Gingival crevicular fluid vascular endothelial cell growth factor and platelet-derived growth factor-BB release profile following the use of perforated barrier membranes during treatment of intrabony defects: a randomized clinical trial. Gamal AY; Abdel-Ghaffar KA; Iacono VJ J Periodontal Res; 2016 Jun; 51(3):407-16. PubMed ID: 26549803 [TBL] [Abstract][Full Text] [Related]
3. A novel marginal periosteal pedicle graft as an autogenous guided tissue membrane for the treatment of intrabony periodontal defects. Gamal AY; Mailhot JM J Int Acad Periodontol; 2008 Oct; 10(4):106-17. PubMed ID: 19055224 [TBL] [Abstract][Full Text] [Related]
4. Gingival crevicular fluid bone morphogenetic protein-2 release profile following the use of modified perforated membrane barriers in localized intrabony defects: a randomized clinical trial. Gamal AY; Aziz M; Salama MH; Iacono VJ J Int Acad Periodontol; 2014 Apr; 16(2):55-63. PubMed ID: 24844029 [TBL] [Abstract][Full Text] [Related]
5. Periodontal regeneration in humans using recombinant human platelet-derived growth factor-BB (rhPDGF-BB) and allogenic bone. Nevins M; Camelo M; Nevins ML; Schenk RK; Lynch SE J Periodontol; 2003 Sep; 74(9):1282-92. PubMed ID: 14584860 [TBL] [Abstract][Full Text] [Related]
6. Autogenous periosteal barrier membranes and bone grafts in the treatment of periodontal intrabony defects of single-rooted teeth: a 12-month reentry randomized controlled clinical trial. Paolantonio M; Femminella B; Coppolino E; Sammartino G; D'Arcangelo C; Perfetti G; Perinetti G J Periodontol; 2010 Nov; 81(11):1587-95. PubMed ID: 20583915 [TBL] [Abstract][Full Text] [Related]
7. Gingival Crevicular Fluid Release Profile of Vascular Endothelial Cell Growth Factor and Platelet-Derived Growth Factors-BB Following Minimally Invasive Flap Reflection during Treatment of Intrabony Defects: A Randomized Clinical Trial. Alzahrani AS J Int Acad Periodontol; 2017 Dec; 20(1):3-11. PubMed ID: 31473715 [TBL] [Abstract][Full Text] [Related]
8. Platelet derived growth factor-BB levels in gingival crevicular fluid of localized intrabony defect sites treated with platelet rich fibrin membrane or collagen membrane containing recombinant human platelet derived growth factor-BB: A randomized clinical and biochemical study. Joshi AA; Padhye AM; Gupta HS J Periodontol; 2019 Jul; 90(7):701-708. PubMed ID: 30637748 [TBL] [Abstract][Full Text] [Related]
9. Role of space provision in regeneration of localized two-wall intrabony defects using periosteal pedicle graft as an autogenous guided tissue membrane. Singhal R; Nandlal ; Kumar A; Rastogi P J Periodontol; 2013 Mar; 84(3):316-24. PubMed ID: 22612365 [TBL] [Abstract][Full Text] [Related]
10. Crevicular Fluid Growth Factors Release Profile Following the Use of Platelet-Rich Fibrin and Plasma Rich Growth Factors in Treating Periodontal Intrabony Defects: A Randomized Clinical Trial. Gamal AY; Abdel Ghaffar KA; Alghezwy OA J Periodontol; 2016 Jun; 87(6):654-62. PubMed ID: 26876351 [TBL] [Abstract][Full Text] [Related]
11. Effect of titanium-prepared platelet-rich fibrin treatment on the angiogenic biomarkers in gingival crevicular fluid in infrabony defects of patients with chronic periodontitis: A randomized controlled clinical trial. Pirebas HG; Hendek MK; Kisa U; Yalim M; Erdemir EO Niger J Clin Pract; 2018 Jan; 21(1):69-75. PubMed ID: 29411727 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of gingival crevicular fluid transforming growth factor-β1 level after treatment of intrabony periodontal defects with enamel matrix derivatives and autogenous bone graft: A randomized controlled clinical trial. Agrali ÖB; Kuru BE; Yarat A; Kuru L Niger J Clin Pract; 2016; 19(4):535-43. PubMed ID: 27251974 [TBL] [Abstract][Full Text] [Related]
13. Surgical treatment of periodontal intrabony defects with calcium sulfate implant and barrier versus collagen barrier or open flap debridement alone: a 12-month randomized controlled clinical trial. Paolantonio M; Perinetti G; Dolci M; Perfetti G; Tetè S; Sammartino G; Femminella B; Graziani F J Periodontol; 2008 Oct; 79(10):1886-93. PubMed ID: 18834243 [TBL] [Abstract][Full Text] [Related]
14. Expression of growth factors in the gingival crevice fluid of patients with phenytoin-induced gingival enlargement. Kuru L; Yilmaz S; Kuru B; Köse KN; Noyan U Arch Oral Biol; 2004 Nov; 49(11):945-50. PubMed ID: 15353252 [TBL] [Abstract][Full Text] [Related]
15. Advantages of Autologous Platelet-Rich Fibrin Membrane on Gingival Crevicular Fluid Growth Factor Levels and Periodontal Healing: A Randomized Split-Mouth Clinical Study. Arabacı T; Kose O; Albayrak M; Cicek Y; Kizildag A J Periodontol; 2017 Aug; 88(8):771-777. PubMed ID: 28452623 [TBL] [Abstract][Full Text] [Related]
16. Single versus double flap approach in periodontal regenerative treatment. Schincaglia GP; Hebert E; Farina R; Simonelli A; Trombelli L J Clin Periodontol; 2015 Jun; 42(6):557-66. PubMed ID: 25924545 [TBL] [Abstract][Full Text] [Related]
17. Randomized controlled clinical study of rhPDGF-BB + β-TCP versus HA + β-TCP for the treatment of infrabony periodontal defects: clinical and radiographic results. Thakare K; Deo V Int J Periodontics Restorative Dent; 2012 Dec; 32(6):689-96. PubMed ID: 23057058 [TBL] [Abstract][Full Text] [Related]
18. Five-year clinical results for treatment of intrabony defects with EMD, guided tissue regeneration and open-flap debridement: a case series. Mitani A; Takasu H; Horibe T; Furuta H; Nagasaka T; Aino M; Fukuda M; Fujimura T; Mogi M; Noguchi T J Periodontal Res; 2015 Feb; 50(1):123-30. PubMed ID: 24815103 [TBL] [Abstract][Full Text] [Related]
19. A phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease. Howell TH; Fiorellini JP; Paquette DW; Offenbacher S; Giannobile WV; Lynch SE J Periodontol; 1997 Dec; 68(12):1186-93. PubMed ID: 9444594 [TBL] [Abstract][Full Text] [Related]
20. Growth factor-mediated treatment of recession defects: a randomized controlled trial and histologic and microcomputed tomography examination. McGuire MK; Scheyer ET; Schupbach P J Periodontol; 2009 Apr; 80(4):550-64. PubMed ID: 19335074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]